Emergo Therapeutics

Emergo Therapeutics is listed on ClinicalTrials.gov as the lead sponsor of 4 studies; the most recently updated is “Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness” (Phase 2, completed), in Influenza, Influenza -Like Illness. From public records Source · Oct 12, 2026

Keywords: From press sources: respiratory allergic rhinitis